These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The pleiotrophin-ALK axis is required for tumorigenicity of glioblastoma stem cells. Koyama-Nasu R; Haruta R; Nasu-Nishimura Y; Taniue K; Katou Y; Shirahige K; Todo T; Ino Y; Mukasa A; Saito N; Matsui M; Takahashi R; Hoshino-Okubo A; Sugano H; Manabe E; Funato K; Akiyama T Oncogene; 2014 Apr; 33(17):2236-44. PubMed ID: 23686309 [TBL] [Abstract][Full Text] [Related]
3. Sox10 has a broad expression pattern in gliomas and enhances platelet-derived growth factor-B--induced gliomagenesis. Ferletta M; Uhrbom L; Olofsson T; Pontén F; Westermark B Mol Cancer Res; 2007 Sep; 5(9):891-7. PubMed ID: 17855658 [TBL] [Abstract][Full Text] [Related]
4. Ink4a-Arf loss cooperates with KRas activation in astrocytes and neural progenitors to generate glioblastomas of various morphologies depending on activated Akt. Uhrbom L; Dai C; Celestino JC; Rosenblum MK; Fuller GN; Holland EC Cancer Res; 2002 Oct; 62(19):5551-8. PubMed ID: 12359767 [TBL] [Abstract][Full Text] [Related]
5. A recombinant lentiviral PDGF-driven mouse model of proneural glioblastoma. Rahme GJ; Luikart BW; Cheng C; Israel MA Neuro Oncol; 2018 Feb; 20(3):332-342. PubMed ID: 29016807 [TBL] [Abstract][Full Text] [Related]
6. MELK-dependent FOXM1 phosphorylation is essential for proliferation of glioma stem cells. Joshi K; Banasavadi-Siddegowda Y; Mo X; Kim SH; Mao P; Kig C; Nardini D; Sobol RW; Chow LM; Kornblum HI; Waclaw R; Beullens M; Nakano I Stem Cells; 2013 Jun; 31(6):1051-63. PubMed ID: 23404835 [TBL] [Abstract][Full Text] [Related]
7. Girdin maintains the stemness of glioblastoma stem cells. Natsume A; Kato T; Kinjo S; Enomoto A; Toda H; Shimato S; Ohka F; Motomura K; Kondo Y; Miyata T; Takahashi M; Wakabayashi T Oncogene; 2012 May; 31(22):2715-24. PubMed ID: 22020337 [TBL] [Abstract][Full Text] [Related]
8. A Tumor Suppressor Function for Notch Signaling in Forebrain Tumor Subtypes. Giachino C; Boulay JL; Ivanek R; Alvarado A; Tostado C; Lugert S; Tchorz J; Coban M; Mariani L; Bettler B; Lathia J; Frank S; Pfister S; Kool M; Taylor V Cancer Cell; 2015 Dec; 28(6):730-742. PubMed ID: 26669487 [TBL] [Abstract][Full Text] [Related]
9. Gliomagenesis arising from Pten- and Ink4a/Arf-deficient neural progenitor cells is mediated by the p53-Fbxw7/Cdc4 pathway, which controls c-Myc. Kim HS; Woolard K; Lai C; Bauer PO; Maric D; Song H; Li A; Kotliarova S; Zhang W; Fine HA Cancer Res; 2012 Nov; 72(22):6065-75. PubMed ID: 22986743 [TBL] [Abstract][Full Text] [Related]
10. Arsenic trioxide disrupts glioma stem cells via promoting PML degradation to inhibit tumor growth. Zhou W; Cheng L; Shi Y; Ke SQ; Huang Z; Fang X; Chu CW; Xie Q; Bian XW; Rich JN; Bao S Oncotarget; 2015 Nov; 6(35):37300-15. PubMed ID: 26510911 [TBL] [Abstract][Full Text] [Related]
11. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells. Stangeland B; Mughal AA; Grieg Z; Sandberg CJ; Joel M; Nygård S; Meling T; Murrell W; Vik Mo EO; Langmoen IA Oncotarget; 2015 Sep; 6(28):26192-215. PubMed ID: 26295306 [TBL] [Abstract][Full Text] [Related]
12. Oligodendrocyte progenitor cells can act as cell of origin for experimental glioma. Lindberg N; Kastemar M; Olofsson T; Smits A; Uhrbom L Oncogene; 2009 Jun; 28(23):2266-75. PubMed ID: 19421151 [TBL] [Abstract][Full Text] [Related]
13. Driver or passenger effects of augmented c-Myc and Cdc20 in gliomagenesis. Ji P; Zhou X; Liu Q; Fuller GN; Phillips LM; Zhang W Oncotarget; 2016 Apr; 7(17):23521-9. PubMed ID: 26993778 [TBL] [Abstract][Full Text] [Related]
14. Tumour-associated macrophages secrete pleiotrophin to promote PTPRZ1 signalling in glioblastoma stem cells for tumour growth. Shi Y; Ping YF; Zhou W; He ZC; Chen C; Bian BS; Zhang L; Chen L; Lan X; Zhang XC; Zhou K; Liu Q; Long H; Fu TW; Zhang XN; Cao MF; Huang Z; Fang X; Wang X; Feng H; Yao XH; Yu SC; Cui YH; Zhang X; Rich JN; Bao S; Bian XW Nat Commun; 2017 Jun; 8():15080. PubMed ID: 28569747 [TBL] [Abstract][Full Text] [Related]
15. Enhanced antitumorigenic effects in glioblastoma on double targeting of pleiotrophin and its receptor ALK. Grzelinski M; Steinberg F; Martens T; Czubayko F; Lamszus K; Aigner A Neoplasia; 2009 Feb; 11(2):145-56. PubMed ID: 19177199 [TBL] [Abstract][Full Text] [Related]
16. Loss of Tsc1 accelerates malignant gliomagenesis when combined with oncogenic signals. Yamada D; Hoshii T; Tanaka S; Hegazy AM; Kobayashi M; Tadokoro Y; Ohta K; Ueno M; Ali MA; Hirao A J Biochem; 2014 Apr; 155(4):227-33. PubMed ID: 24368778 [TBL] [Abstract][Full Text] [Related]
17. Constitutive activation of Notch2 signalling confers chemoresistance to neural stem cells via transactivation of fibroblast growth factor receptor-1. Tomé M; Tchorz J; Gassmann M; Bettler B Stem Cell Res; 2019 Mar; 35():101390. PubMed ID: 30763736 [TBL] [Abstract][Full Text] [Related]
18. PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo. Dai C; Celestino JC; Okada Y; Louis DN; Fuller GN; Holland EC Genes Dev; 2001 Aug; 15(15):1913-25. PubMed ID: 11485986 [TBL] [Abstract][Full Text] [Related]
19. PDGFRα depletion attenuates glioblastoma stem cells features by modulation of STAT3, RB1 and multiple oncogenic signals. Cenciarelli C; Marei HE; Felsani A; Casalbore P; Sica G; Puglisi MA; Cameron AJ; Olivi A; Mangiola A Oncotarget; 2016 Aug; 7(33):53047-53063. PubMed ID: 27344175 [TBL] [Abstract][Full Text] [Related]
20. PDGF activation in PGDS-positive arachnoid cells induces meningioma formation in mice promoting tumor progression in combination with Nf2 and Cdkn2ab loss. Peyre M; Salaud C; Clermont-Taranchon E; Niwa-Kawakita M; Goutagny S; Mawrin C; Giovannini M; Kalamarides M Oncotarget; 2015 Oct; 6(32):32713-22. PubMed ID: 26418719 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]